Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product

[1]  P. Borrow,et al.  SAP controls T cell responses to virus and terminal differentiation of TH2 cells , 2001, Nature Immunology.

[2]  P. Engel,et al.  X-linked lymphoproliferative disease: a progressive immunodeficiency. , 2001, Annual review of immunology.

[3]  A. Weiss,et al.  Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines , 2001, Nature Immunology.

[4]  V. Schuster,et al.  X‐linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain‐containing signal transduction adaptor protein , 2000, Immunological reviews.

[5]  J. Schatzle,et al.  Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. , 2000, International immunology.

[6]  M. Colonna,et al.  Patients with X‐linked lymphoproliferative disease have a defect in 2B4 receptor‐mediated NK cell cytotoxicity , 2000, European journal of immunology.

[7]  H. Hayasawa,et al.  p56dok‐2 as a cytokine‐inducible inhibitor of cell proliferation and signal transduction , 2000 .

[8]  S. Tangye,et al.  Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome1 , 2000, The Journal of Immunology.

[9]  D I Stuart,et al.  Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. , 2000, The Journal of biological chemistry.

[10]  L. Notarangelo,et al.  X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .

[11]  S. Latour,et al.  Dok-3, a Novel Adapter Molecule Involved in the Negative Regulation of Immunoreceptor Signaling , 2000, Molecular and Cellular Biology.

[12]  D. Olive,et al.  Tec kinases: a family with multiple roles in immunity. , 2000, Immunity.

[13]  P. Bruhns,et al.  The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. , 2000, Immunity.

[14]  D. Baltimore,et al.  Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. , 2000, Genes & development.

[15]  H. Hayasawa,et al.  p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction. , 2000, The EMBO journal.

[16]  M. Colonna,et al.  2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. , 2000, Human immunology.

[17]  T. Pawson,et al.  Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A , 1999, Current Biology.

[18]  S. Tangye,et al.  Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. , 1999, Journal of immunology.

[19]  C Terhorst,et al.  Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. , 1999, Molecular cell.

[20]  S. Tangye,et al.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.

[21]  A. Weiss,et al.  Induction of NF-κB by the Akt/PKB kinase , 1999, Current Biology.

[22]  L. M. Shlapatska,et al.  CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. , 1999, Journal of immunology.

[23]  E. Snyder,et al.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Penninger,et al.  The Inositol Polyphosphate 5-Phosphatase Ship Is a Crucial Negative Regulator of B Cell Antigen Receptor Signaling , 1998, The Journal of experimental medicine.

[25]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[26]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[27]  G. Krystal,et al.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. , 1998, Genes & development.

[28]  P. Pandolfi,et al.  Molecular Cloning and Characterization of p56 dok-2 Defines a New Family of RasGAP-binding Proteins* , 1998, The Journal of Biological Chemistry.

[29]  P. Pandolfi,et al.  Molecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding Proteins* , 1998 .

[30]  S. Latour,et al.  Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase , 1997, Molecular and cellular biology.

[31]  B. Cocks,et al.  Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. , 1997, Journal of immunology.

[32]  D. Baltimore,et al.  Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok , 1997, Cell.

[33]  R. Kobayashi,et al.  p62 dok : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells , 1997, Cell.

[34]  C. Denny,et al.  EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. , 1996, Oncogene.

[35]  A. Veillette,et al.  The Src and Csk families of tyrosine protein kinases in hemopoietic cells. , 1995, Seminars in immunology.

[36]  B. Cocks,et al.  A novel receptor involved in T-cell activation , 1995, Nature.

[37]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[38]  J. M. Lee,et al.  The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site , 1993, Molecular and cellular biology.

[39]  G. Gish,et al.  Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins. , 1993, Oncogene.

[40]  P. Stein,et al.  pp59 fyn mutant mice display differential signaling in thymocytes and peripheral T cells , 1992, Cell.

[41]  M. Fournel,et al.  Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn , 1992, The Journal of experimental medicine.

[42]  J. Parnes,et al.  The roles of CD4 and CD8 in T cell activation. , 1991, Seminars in immunology.

[43]  N. Abraham,et al.  Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck , 1991, Nature.

[44]  Cook Mp,et al.  Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. , 1989 .

[45]  R. Perlmutter,et al.  Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. , 1989, The New biologist.

[46]  Michael A. Bookman,et al.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.

[47]  J. Bluestone,et al.  Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Nelson,et al.  A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac. , 1985, Hybridoma.

[49]  P. Marrack,et al.  Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. , 1983, Journal of immunology.